Furthermore, the anti-tumor activity of IL-12 was found greatly reduced in both NK cell-deficient mice and IFN-γ-deficient mice, suggesting that NK cells and IFN-γ are the primary factors that mediate the anti-tumor effects of IL-12 in lung cancer models. The gene discussed is IFNG; the disease is lung cancer.